XML 100 R53.htm IDEA: XBRL DOCUMENT v3.25.1
Intangible Assets (Tables)
12 Months Ended
Dec. 31, 2024
Intangible assets other than goodwill [abstract]  
Summary of Reconciliation of Changes in Intangible Assets and Goodwill
Rights to
Produce and
Distribute Coca-Cola Trademark Products
GoodwillTrademark RightsOther
Indefinite Lived Intangible
Assets
Total Unamortized Intangible
Assets
Technology Costs and Management Systems
Customer Relationships (1)
Alcohol
Licenses
OtherTotal Amortized Intangible
Assets
Total Intangible
Assets
Cost as of January 1, 2022Ps.75,396 Ps.57,351 Ps.8,073 Ps.1,413 Ps.142,233 Ps.10,661 Ps.10,800 Ps.2,006 Ps.2,470 Ps.25,937 Ps.168,170 
Additions — 22 — 12 34 672 — 50 1,476 2,198 2,232 
Acquisitions from business combinations (see Note 4) 1,116 33,715 1,077 — 35,908 373 — — 1,054 1,427 37,335 
Changes in fair value of past acquisitions— (2,557)— — (2,557)— 2,955 — — 2,955 398 
Internal developments— — — — — 10 — — — 10 10 
Transfer of completed development systems — — — — — 65 — (50)(15)— — 
Disposals — — — (2)(2)(891)(3)(29)— (923)(925)
Effect of movements in exchange rates (756)(2,057)(106)(158)(3,077)15 (264)— 466 217 (2,860)
Changes in value on the recognition of inflation effects — — — — — — — — 80 80 80 
Impairment— (770)— — (770)— — — — — (770)
Cost as of December 31, 2022Ps.75,756 Ps.85,704 Ps.9,044 Ps.1,265 Ps.171,769 Ps.10,905 Ps.13,488 Ps.1,977 Ps.5,531 Ps.31,901 Ps.203,670 
(1)Includes customer relationships related to the acquisitions through Envoy Solutions disclosed in Note 4.
Rights to
Produce and
Distribute Coca-Cola Trademark
Products
GoodwillTrademark RightsOther
Indefinite Lived Intangible
Assets
Total Unamortized Intangible
Assets
Technology Costs and Management Systems
Customer Relationships (1)
Alcohol
Licenses
OtherTotal Amortized Intangible
Assets
Total Intangible
Assets
Cost as of January 1, 2023Ps.75,756Ps.85,704Ps.9,044Ps.1,265Ps.171,769Ps.10,905Ps.13,488Ps.1,977Ps.5,531Ps.31,901Ps.203,670
Additions 441,9662611,1743,4013,405
Acquisitions from business combinations (see Note 4) 3,918263,944145188253584,302
Changes in fair value of past acquisitions(12,273)7,683(4,590)5,162(117)5,045455
Business disposals(12)(25,036)(3,009)(56)(28,113)(482)(17,788)(29)(18,299)(46,412)
Transfer of completed development systems (224)2273292(295)(3)
Disposals (2)(2)(4)(197)(161)(235)(593)(597)
Effect of movements in exchange rates (1,568)(3,744)(810)45(6,077)(424)(814)(683)(1,921)(7,998)
Changes in value on the recognition of inflation effects707070
Impairment (4,995)(4,995)(4,995)
Business combinations from disposals1,9501,9501,950
Cost as of December 31, 2023 Ps.73,952Ps.45,522Ps.12,934Ps.1,483Ps.133,891Ps.12,205Ps.236Ps.2,077Ps.5,441Ps.19,959Ps.153,850
(1)Includes customer relationships related to the acquisitions through Envoy Solutions disclosed in Note 4.
Rights to
Produce and
Distribute Coca-Cola Trademark
Products
GoodwillTrademark RightsOther
Indefinite Lived Intangible
Assets
Total Unamortized Intangible
Assets
Technology Costs and Management SystemsCustomer RelationshipsAlcohol
Licenses
OtherTotal Amortized Intangible
Assets
Total Intangible
Assets
Cost as of January 1, 2024Ps.73,952Ps.45,522Ps.12,934Ps.1,483Ps.133,891Ps.12,205Ps.236Ps.2,077Ps.5,441Ps.19,959Ps.153,850
Additions 461955561,7743881,2103,0753,631
Acquisitions from business combinations (see Note 4) 2,8092,8091,2161,2164,025
Changes in fair value of past acquisitions(3)3
Transfer of completed development systems 670(670)
Disposals (50)(50)(76)(31)(107)(157)
Effect of movements in exchange rates 657(371)289225972,434466145(867)2,1782,775
Changes in value on the recognition of inflation effects256(123)133133
Impairment (1,797)(1,004)(2,801)(2,801)
Cost as of December 31, 2024Ps.74,609Ps.46,624Ps.12,219Ps.1,550Ps.135,002Ps.17,263Ps.702Ps.2,310Ps.6,179Ps.26,454Ps.161,456


Amortization and Impairment LossesRights to
Produce and
Distribute Coca-Cola Trademark
Products
GoodwillTrademark RightsOther
Indefinite Lived Intangible
Assets
Total Unamortized Intangible
Assets
Technology Costs and Management SystemsCustomer RelationshipsAlcohol
Licenses
OtherTotal Amortized Intangible
Assets
Total Intangible
Assets
Amortization as of January 1 2022Ps.Ps.Ps.Ps.Ps.Ps.(6,414)Ps.(1,608)Ps.(838)Ps.(1,172)Ps.(10,032)Ps.(10,032)
Amortization expense (1,312)(915)(104)(365)(2,696)(2,696)
Disposals99215731,1521,152
Effect of movements in exchange rates (193)(786)(248)(1,227)(1,227)
Changes in value on the recognition of inflation effects(94)(1)(95)(95)
Amortization as of December 31 2022 Ps.Ps.Ps.Ps.Ps.Ps.(7,021)Ps.(3,152)Ps.(939)Ps.(1,786)Ps.(12,898)Ps.(12,898)
Amortization as of January 1 2023 Ps.Ps.Ps.Ps.Ps.Ps.(7,021)Ps.(3,152)Ps.(939)Ps.(1,786)Ps.(12,898)Ps.(12,898)
Amortization expense (1,519)(1,113)(116)(547)(3,295)(3,295)
Disposals 161209370370
Business disposals2764,010514,3374,337
Impairment(36)(36)(36)
Effect of movements in exchange rates 57818815187968968
Changes in value on the recognition of inflation effects(78)(78)(78)
Amortization as of December 31 2023 Ps.Ps.Ps.(36)Ps.Ps.(36)Ps.(7,603)Ps.(67)Ps.(1,040)Ps.(1,886)Ps.(10,596)Ps.(10,632)
Amortization as of January 1 2024 Ps.Ps.Ps.(36)Ps.Ps.(36)Ps.(7,603)Ps.(67)Ps.(1,040)Ps.(1,886)Ps.(10,596)Ps.(10,632)
Amortization expense (1,895)(17)(226)(479)(2,617)(2,617)
Disposals 562728585
Effect of movements in exchange rates (745)(745)(648)(413)126(147)(1,082)(1,827)
Changes in value on the recognition of inflation effects (129)(129)(129)
Amortization as of December 31 2024 Ps.(745)Ps.Ps.(36)Ps.Ps.(781)Ps.(10,219)Ps.(470)Ps.(1,140)Ps.(2,510)Ps.(14,339)Ps.(15,120)

Carrying AmountRights to
Produce and
Distribute Coca-Cola Trademark
Products
GoodwillTrademark RightsOther
Indefinite Lived Intangible
Assets
Total Unamortized Intangible
Assets
Technology Costs and Management SystemsCustomer RelationshipsAlcohol
Licenses
OtherTotal Amortized Intangible
Assets
Total Intangible
Assets
As of December 31 2022Ps.75,756Ps.85,704Ps.9,044Ps.1,265Ps.171,769Ps.3,884Ps.10,336Ps.1,038Ps.3,745Ps.19,003Ps.190,772
As of December 31 2023 Ps.73,952Ps.45,522Ps.12,898Ps.1,483Ps.133,855Ps.4,602Ps.169Ps.1,037Ps.3,555Ps.9,363Ps.143,218
As of December 31 2024 Ps.73,864Ps.46,624Ps.12,183Ps.1,550Ps.134,221Ps.7,044Ps.232Ps.1,170Ps.3,669Ps.12,115Ps.146,336
Schedule of Allocation of Amortization Expenses
For the years ended December 31, 2024, December 31, 2023 and 2022, allocation for amortization expense is as follows:
    202420232022
 
Cost of goods sold Ps.49 Ps.1,229 Ps.207 
Administrative expenses 649 1,257 1,771 
Selling expenses 1,919 809 718 
 Ps.2,617 Ps.3,295 Ps.2,696 
Summary of Average Remaining Period for Company's Intangible Assets Subject to Amortization
The average remaining period for the Company’s intangible assets that are subject to amortization is as follows:
 Years
Technology Costs and Management Systems 
3 - 10
Customer Relationships
6 - 25
Alcohol Licenses 12
Disclosure of Aggregate Carrying Amounts of Goodwill and Distribution Rights Allocated to Each CGU
The aggregate carrying amounts of goodwill, distribution rights and other indefinite lived intangible assets allocated to each CGU are as follows:
December 31, 2024December 31, 2023
MexicoPs.57,689Ps.56,662
Guatemala1,6951,684
Nicaragua404404
Costa Rica1,4391,418
Panama1,1701,169
Colombia3,6383,635
Brazil28,19930,018
Argentina512245
Uruguay2,4522,381
TotalPs.97,198Ps.97,616
Details of Key Assumptions by CGU for Impairment Test
The key assumptions by CGU for impairment testing as of December 31, 2024 were as follows:
Pre-tax WACCPost-tax WACCExpected Annual Long-Term InflationExpected
Volume Growth Rates
CGU2025‑20292025‑2029
Mexico 9.0%6.3%4.1%5.4%
Brazil 10.9%6.8%3.6%4.1%
Colombia 12.0%7.9%3.1%6.6%
Argentina 16.0%12.0%35.1%4.5%
Guatemala 9.5%7.2%4.0%11.9%
Costa Rica 12.0%8.5%2.8%6.6%
Nicaragua 23.0%13.1%3.5%6.5%
Panama 11.7%9.1%1.8%6.3%
Uruguay 9.5%7.1%5.1%4.2%

The key assumptions by CGU for impairment testing as of December 31, 2023 were as follows:
Pre-tax WACCPost-tax WACCExpected Annual
Long-Term Inflation
Expected
Volume Growth Rates
CGU2024‑20282024‑2028 
Mexico 9.0%6.3%4.3%4.4%
Brazil 10.1%6.8%3.8%3.8%
Colombia 12.2%7.7%4.2%6.8%
Argentina 20.8%16.1%70.8%4.8%
Guatemala 9.3%7.3%4.0%14.9%
Costa Rica 11.4%8.8%2.9%6.6%
Nicaragua 23.3%16.4%2.6%6.5%
Panama11.6%8.6%2.0%7.8%
Uruguay 9.7%7.4%5.7%3.7%
The key assumptions by the significant CGU (Chile) in the Health Division (Mexico, Colombia and Ecuador are insignificant) for impairment test as of December 31, 2024 was as follows:
CGUPre-tax WACCPost-tax WACCExpected Annual
Long-Term 
Inflation
2025‑2029
Expected Sales Growth Rate
Chile 6.8%5.9%3.1%1.9%

The key assumptions by the significant CGU in the Health Division for impairment test as of December 31, 2023 was as follows:
CGUPre-tax WACCPost-tax WACCExpected Annual
Long-Term 
Inflation
2024‑2028
Expected Sales Growth Rates 2024‑2028
Chile7.3 %6.4 %2.6 %0.2 %
The key assumptions by CGU for impairment test as of December 31, 2024 were as follows:

CGUPre-tax WACCPost-tax WACCExpected Annual
Long-Term 
Inflation
2025‑2029
Expected Sales Growth Rates
Valora 5.7%5.3%1.0%4.5%
The key assumptions by CGU for impairment test as of December 31, 2023 was as follows:
CGUPre-tax WACCPost-tax WACCExpected Annual Long-Term Inflation 2024‑2028Expected Sales Growth Rates 2024‑2028
Valora 5.8%5.5%1.4%0.2%
Disclosure of Detailed Information About Sensitivity to Changes in Assumptions
                    
CGUChange in post-tax WACC
Change in Expected Volume Growth CAGR (1)
Effect on Valuation
Mexico 
+0.4
p.p.-1.0%Passes by 5x
Brazil 
+0.5
p.p.-1.0%Passes by 1.9x
Colombia 
+0.7
p.p.-1.0%Passes by 2.5x
Argentina 
+1.7
p.p.-1.0%Passes by 5x
Guatemala 
+0.5
p.p.-1.0%Passes by 7.3x
Costa Rica 
+0.5
p.p.-1.0%Passes by 3.9x
Nicaragua 
+1.7
p.p.-1.0%Passes by 2.1x
Panama 
+0.6
p.p.-1.0%Passes by 3.6x
Uruguay 
+0.1
p.p.-1.0%Passes by 3x
(1)Compound Annual Growth Rate (“CAGR”).
The sensitivity test by the significant CGU in the Health Division as of December 31, 2024 was as follows:
CGUChange in WACCChange in Expected Sales Growth Rates CAGREffect on Valuation
Chile 0.3p.p.(0.5)%Passes by 6.24x
On December 31, 2024, the Company performed an additional impairment sensitivity calculation, taking into account an effect of 50 basis points in the sale’s compound annual growth rate (“CAGR”), concluding that no impairment would be recognized.

CGUChange in Expected Sales Growth CAGREffect on Valuation
Valora (0.5)%Passes by 1.45x